Stocksigma LogoStocksigma Logo

Nuvama Wealth Reports Strong Q2 Results and Approves ₹700 Cr Subsidiary Capital Infusion

Nuvama Wealth Management approved Q2 results ending 30th Sep'26, reporting a 21% YoY increase in consolidated revenue to ₹937 Cr and a 26% YoY rise in

Nuvama Wealth Reports Strong Q2 Results and Approves ₹700 Cr Subsidiary Capital Infusion

Nuvama Wealth Management Ltd · Others (Uncategorized) · 06 Nov 2026, 7:45 pm

Nuvama Wealth Reports Strong Q2 Results and Approves ₹700 Cr Subsidiary Capital Infusion Nuvama Wealth Management approved Q2 results ending 30th Sep'26, reporting a 21% YoY increase in consolidated revenue to ₹937 Cr and a 26% YoY rise in operating PAT to ₹319 Cr (reported PAT up 19% YoY to ₹304 Cr). Total client assets surged 25% YoY to ₹5.5 trillion, supported by record quarterly net flows. Additionally, the board approved equity investments up to ₹400 Cr in Nuvama Wealth Finance and up to ₹300 Cr in Nuvama Wealth and Investment to fund general business growth.

Original exchange filing (PDF)

More announcements from Nuvama Wealth Management Ltd

All Nuvama Wealth Management Ltd announcements